Full-Time

Legal Counsel

Orbem

Orbem

201-500 employees

AI-powered MRI sorting for food processing

Compensation Overview

€120k - €135k/yr

Munich, Germany

Hybrid

Hybrid work in Munich; relocation support is available for a move to Germany.

Bachelor's

Category
Legal & Compliance (2)
,

Get referred to Orbem

See people who can refer or advise you

Requirements
  • Be a qualified German lawyer—Volljurist or Wirtschaftsjurist, or equivalent—with strong in-house experience in a fast-paced environment.
  • Have a solid foundation in German corporate and commercial contract law, with a focus on B2B operations.
  • Have personally established legal or compliance processes, templates, and frameworks, including drafting, running workshops, and participating in working meetings.
  • Be comfortable working without a large team.
  • Make pragmatic, risk-balanced, business-minded decisions in a scale-up environment.
  • Be comfortable coordinating multi-jurisdictional matters, especially across the European Union and the United States, with external counsel.
  • Translate complex legal issues into practical, commercially sound advice for non-legal stakeholders.
  • Be fluent in German and English.
Responsibilities
  • Draft and negotiate commercial contracts, including integrated hardware sale or lease, software and artificial intelligence licensing, service and maintenance agreements, supplier agreements, and partner agreements.
  • Build and own the contract toolkit, including templates, playbooks, and a review-to-signing workflow.
  • Own corporate and governance matters, including corporate housekeeping, board and shareholder support, and the employee equity program.
  • Advise on employment matters and manage disputes and litigation in partnership with external counsel.
  • Establish Orbem’s cross-functional compliance function for identifying, aligning on, and managing risk across the business.
  • Partner across intellectual property, information security, product compliance, and data protection to translate obligations into practical standards.
  • Drive regulatory readiness for the European Union Artificial Intelligence Act, Cyber Resilience Act, export control, and data protection requirements.
  • Own the Code of Conduct and core policies.
  • Manage a lean group of external firms, including corporate, United States, and employment counsel, while optimizing cost, consistency, and global strategy.
  • Act as the central hub for legal and compliance across Orbem and participate early in business decisions.
  • Embed legal as a proactive enabler in fast-moving business workflows and use artificial intelligence and legal tooling to keep the function lean and scalable.
  • Work across the company and advise the full executive team on legal and compliance decisions.
Desired Qualifications
  • In-house experience at a hardware-focused technology company or deep-tech scale-up.
  • A track record of building compliance frameworks from scratch across areas such as data protection, product and trade compliance, anti-corruption, or artificial intelligence governance.
  • Experience with product liability and product safety in a commercial context.
  • Comfort using artificial intelligence to accelerate legal work while owning the resulting output.

Orbem.ai uses AI and MRI to help food processors reduce waste and improve efficiency. Its Genus system scans, classifies, and sorts items like eggs, nuts, and seeds to detect defects and viability. By combining artificial intelligence with MRI, it delivers fast, accurate imaging with minimal software and hardware changes. Its goal is to cut waste and open new revenue streams across poultry, seed breeding, and nut industries.

Company Size

201-500

Company Stage

Series B

Total Funding

$101.4M

Headquarters

Munich, Germany

Founded

2019

Get referred to Orbem

See people who can refer or advise you

Simplify Jobs

Simplify's Take

What believers are saying

  • Orbem closed a €55.5 million Series B on 2026-01-20 for expansion.
  • JimboFresh began using Genus Echo in May 2026 on 38,000 tonnes.
  • Orbem started US rollout in 2025, and Houston hiring expanded sharply in 2026.

What critics are saying

  • Food-processing sales depend on hatchery capex cycles and producer adoption speed.
  • Scaling MRI hardware across countries creates service bottlenecks before 2027.
  • If US deployment slips, Orbem loses its growth narrative and fundraising leverage.

What makes Orbem unique

  • Orbem industrializes sub-second MRI for eggs and produce, unlike manual inspection rivals.
  • Its proprietary biological dataset grows from 170 million scanned eggs across five countries.
  • Genus Focus and Genus Echo reuse one platform across poultry and produce.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Stock Options

Relocation Support

Learning & Development

Fitness Membership

Childcare Reimbursement

Deutschland Ticket

Flexible Work Hours

Remote Work Options

Home Office Stipend

Paid Vacation

Growth & Insights and Company News

Headcount

6 month growth

0%

1 year growth

0%

2 year growth

1%
Yumda
Jan 22nd, 2026
Orbem secures €55.5 million Series B

Orbem secures €55.5 million Series B. Orbem, the Munich-based Deep tech company turning magnetic resonance imaging (MRI) into a powerful, AI-powered tool to reveal hidden insights in food and biology, announced the successful closing of a €55.5 million Series B financing round. The round is led by European Deep tech specialist Innovation Industries and joined by Supernova Invest, with significant follow-on participation from existing investors General Catalyst, 83North, The Venture Collective, Possible Ventures, and several angel investors. Orbem has developed a breakthrough platform that makes MRI technology fast, affordable and scalable, enabling non-invasive analysis of biological materials at an industrial scale. By doing so, the company is building what is becoming the industry's largest and most comprehensive biological dataset. Already profitable and a leading provider of in-ovo sexing in five European countries, a position built on its deep understanding of poultry industry processes, Orbem will use the new capital to fuel its expansion into the United States, launch new solutions for the poultry industry, and enter the multi-billion-dollar fruit and vegetable market. Additionally, Orbem will invest in its vision to apply its actionable intelligence to human healthcare. Proven success: transparency in the poultry industry. Orbem has already delivered measurable impact in the poultry industry, leveraging its deep industry process knowledge to deliver practical solutions. Its flagship product, the Genus Focus, uses AI-powered MRI to see inside a poultry egg, non-invasively determining its sex in less than one second. This provides an animal-friendly and highly efficient alternative to the culling of male chicks, a practice now banned in several EU countries. With over 170 million eggs scanned to date, Orbem is scaling rapidly, ready to meet increasing global demand spurred by initiatives like the new 'Hatch Check' certification in the US. Building on this success, Orbem recently launched the Genus Scale, a first-of-its-kind product that sees inside eggs to check their fertilization status before incubation. This allows hatcheries to stop wasting valuable incubator space on non-viable eggs, repurposing them for the food industry, creating new revenue streams, and fighting food waste. A new era of growth: scaling and expansion. The Series B funding will accelerate Orbem's mission to solve global challenges by revealing what And Yumda can't see on the outside of food and biology. Key initiatives include: * US Market Entry: After establishing its first US office in Houston, Texas, in 2025, Orbem is bringing its proven poultry solutions to one of the world's largest agricultural markets. * Expanded Poultry Platform: Orbem will continue to strengthen its commitment to the poultry industry, scaling its existing solutions. * New Vertical: Fruits & Vegetables: The company is expanding its actionable intelligence for sustainable food production into the fruit and vegetable sector. Orbem's non-destructive technology can see inside produce like watermelons, avocados and mangoes to spot internal defects and assess quality without cutting them open. This helps producers to sort goods with precision, ensure consistent quality, and dramatically reduce food waste before products reach the consumer. * Healthcare: What Orbem learns from scanning millions of eggs and avocados translates to a deeper understanding of biology. The company is building the world's largest biological dataset. This unique asset is the foundation for AI models that will have profound applications in human health, making non-invasive insights more accessible. Dr. Pedro Gómez, co-founder and CEO of Orbem, says: "We're the first and so far only company in the world to demonstrate the use of MRI in less than one second and without humans in the loop. We began by showing the poultry industry what's possible when you can see inside an egg, and we are just getting started. This new funding allows us to accelerate our US expansion and help more food producers and healthcare providers make better decisions with data. Our scalable platform and our rapidly growing, proprietary biological dataset are the perfect basis for achieving this. We are proud to see the trust our investors have placed in us and our vision to help the world see from the inside out." Pleuni Hooijman, Investment Manager at Innovation Industries, states: "Orbem is truly exceptional. Few companies manage to make such complex technology accessible and scalable across so many industries. With its platform, Orbem is already transforming entire sectors, and we are very pleased to join them on this journey." Michaël Thomas, Investment Director at Supernova Invest, adds: "We're thrilled to join forces with Orbem, a visionary company that perfectly embodies Europe's Deep tech excellence. By combining cutting-edge AI and MRI technologies, Orbem delivers concrete answers to some of the major challenges of our time, from reducing animal suffering to fighting food waste and building a more sustainable global food system. This investment illustrates our conviction that Europe can lead in physical AI, transforming scientific breakthroughs into meaningful industrial innovation."

Tech Funding News
Jan 20th, 2026
Munich's Orbem raises €55.5M to scale AI-powered MRI tech that sees inside eggs, fruit and people

Orbem, a Munich-based deep tech company, has raised €55.5 million in a Series B round led by Innovation Industries, with participation from Supernova Invest, General Catalyst, 83North, The Venture Collective and Possible Ventures. The startup combines MRI sensors with AI to inspect biological materials non-invasively. Its flagship technology can determine a chick embryo's sex inside an egg in under a second, offering an alternative to culling practices. The company's commercial products include Genus Focus for egg sexing and Genus Scale for identifying fertilised eggs before incubation. Founded by Drs Pedro Gómez, Gabriel Brostow and Florian Wuttke, Orbem claims to have industrialised MRI technology at speeds previously unachievable. The funding will support US expansion and extend the technology into fruits, vegetables and healthcare sectors.

Vestbee
Jan 20th, 2026
Orbem raises €55.5M to expand AI-powered MRI solutions for food and health industries

Orbem raises €55.5M to expand AI-powered MRI solutions for food and health industries. Munich-based startup Orbem, which develops AI-powered MRI technology for fast, non-invasive analysis of biological materials, has raised €55.5 million in a Series B financing round led by European deep tech investor Innovation Industries and joined by Supernova Invest as well as existing investors, as Vestbee was informed. * Launched in Munich in 2019, Orbem develops AI-powered Magnetic Resonance Imaging (MRI) technology for the non-invasive analysis of biological materials. * The system combines MRI sensors with AI to extract internal data from objects such as poultry eggs, fruits, nuts, and human tissue. In poultry, it can determine egg sex and fertilization status in under a second; in produce, it identifies internal defects and quality issues. * Orbem began system development in 2020, installed its first Genus 1.0 system in 2021, and expanded into European markets by 2023. * The firm has offices in Munich and Houston and employs more than 170 people across technical, operational, and scientific roles. The MRI platform generates actionable biological data at an industrial scale, forming a growing dataset used for applications in food production and health research. Details of the deal. * The Series B round was led by Innovation Industries, joined by Supernova Invest, and supported by existing investors including General Catalyst, 83North, The Venture Collective, Possible Ventures, and several angel investors. "Orbem is truly exceptional. Few companies manage to make such complex technology accessible and scalable across so many industries. With its platform, Orbem is already transforming entire sectors, and we are very pleased to join them on this journey," explains Pleuni Hooijman, Investment Manager at Innovation Industries. * Orbem will use the €55.5 million funding to expand into the US market, scale its poultry solutions, enter the fruits and vegetables sector to reduce food waste, and invest in applying its AI-powered MRI insights to human healthcare. "This new funding allows us to accelerate our US expansion and help more food producers and healthcare providers make better decisions with data. Our scalable platform and our rapidly growing, proprietary biological dataset are the perfect basis for achieving this. We are proud to see the trust our investors have placed in us and our vision to help the world see from the inside out," claims Dr. Pedro Gómez, co-founder and CEO of Orbem.

AgFunder
Dec 11th, 2024
‘A Pivotal Moment In The Egg Industry…’ Nestfresh Celebrates First Hatch Of In-Ovo Sexed Chicks In The Us

Specialty egg producer NestFresh Eggs celebrated the first hatch of in-ovo sexed chicks in the US on Tuesday at Hy-Line North America’s Iowa hatchery, paving the way for a new category of specialty eggs for US consumers. It plans to transition its entire egg line to this new process, with certified eggs from the sexed chickens launching in retail in July 2025 at retailers including Albertson’s, Harris Teeter, Whole Foods Market, Publix and H-E-B. The technology, which enables hatcheries to sex chicks before they hatch, is designed to end the practice of killing male chicks as soon as they are born as they are of little interest to the industry as they can’t lay eggs, and there’s no viable market for their meat as the breeds of chicken used in egg and meat production are different

Orbem
Sep 2nd, 2024
Hendrix Genetics and Orbem Announce the Successful Launch of MRI-Based Technology for In-Ovo Sexing

Boxmeer, NL and Munich, GE - Hendrix Genetics, the world leader in multi-species breeding and genetics and Orbem, a leading deep-tech imaging and AI technology company, today announced the successful launch of Orbem's Genus Focus system in the Hendrix Genetics laying hen hatchery in Mûr-de-Bretagne, France.